Emerging paradigms in the study of brain metastases
Shawn C Chafe1,2, Daniel Mobilio1,3, Kui Zhai1,2
1Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON L8S 4M1, Canada.
Abstract:
Brain metastases arise from the spread of cancer cells from tumors residing outside the brain. Immunotherapy and molecularly targeted therapeutics have improved outcomes for some patients with brain metastases, but many patients are still faced with a dismal prognosis. The inability to effectively treat these tumors and improve patient survival highlights the dire need for improved therapeutic strategies that ultimately depend on developing a greater understanding of the molecular underpinnings and inner wiring of these tumors. In this Review, we discuss current and emerging insights into the genetics and cellular signaling pathways that contribute to the spread of tumors to the brain. We also discuss potential therapeutic targets in the metabolic vulnerabilities of cells that metastasize to the brain and in the interactions between metastases and the microenvironment.
Insights
Understanding the molecular basis of brain metastases is crucial for developing new treatments. This review explores the genetics, signaling pathways, and microenvironment interactions driving cancer spread to the brain, aiming to improve patient survival.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Translational Medicine
Background:
- Brain metastases originate from extracranial tumors, posing significant treatment challenges.
- Current therapies like immunotherapy offer limited benefits for many patients with brain metastases, necessitating novel strategies.
- A deeper understanding of the molecular mechanisms driving brain metastasis is essential for improving patient outcomes.
Purpose of the Study:
- To review current and emerging insights into the genetic and cellular signaling pathways involved in brain metastasis.
- To explore potential therapeutic targets, including metabolic vulnerabilities and microenvironment interactions.
Main Methods:
- Literature review of genetics and cellular signaling in brain metastasis.
- Analysis of metabolic vulnerabilities in metastatic cells.
- Examination of brain metastasis-microenvironment interactions.
Main Results:
- Identified key genetic and signaling pathways contributing to tumor spread to the brain.
- Highlighted metabolic vulnerabilities exploitable for therapeutic intervention.
- Discussed the role of the tumor microenvironment in brain metastasis progression.
Conclusions:
- Improved therapeutic strategies for brain metastases require a comprehensive understanding of their molecular underpinnings.
- Targeting specific genetic pathways, metabolic vulnerabilities, and microenvironment interactions holds promise for future treatments.
- Further research into the complexities of brain metastasis is critical for enhancing patient survival and prognosis.
